First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

✍ Scribed by Hughes, Bruce; Cascione, Mark; Freedman, Mark S.; Agius, Mark; Kantor, Daniel; Gudesblatt, Mark; Goldstick, Lawrence P.; Agashivala, Neetu; Schofield, Lesley; McCague, Kevin; Hashmonay, Ron; Barbato, Luigi

• Book ID: 125859117
• Publisher: Elsevier
• Year: 2014
• Tongue: English
• Weight: 528 KB
• Volume: 3
• Category: Article
• ISSN: 2211-0348
• DOI: 10.1016/j.msard.2014.06.006